Young-Kwang (YK) Yoon is a Vice President and Head of Clinical Development Strategy at Genome & Co. He joined Genome & Co in 2019, and was a significant contributor to the company’s growth in advancing its lead pipelines in oncology advancing to phase 2 clinical development and overall development pipeline strategy. YK received his Ph.D in Tumor Biology from Seoul National University, Collage of Medicine, and research experiences includes whom genome/transcriptome high-throughput sequencing, mechanism of variable responses to MEK inhibition in KRAS mutant cancer cells and anti-proliferative effect of MEK inhibitor in EGFR wild type gastric cancer cells.